Finance

Lists
0512:HKG
Grand Pharmaceutical Group Ltd
4,59 HKD
-0,86%
(-0,040) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0512...
Open
4,70 HKD
High
4,74 HKD
Low
4,57 HKD
Mkt. cap
16,29 млд
Avg. vol.
3,85 млн
Volume
3,30 млн
Dividend
3,68%
Quarterly dividend
0,04 HKD
Ex-dividend date
2025-ж., 14-апр.
P/E ratio
14,18
52-wk high
8,97 HKD
52-wk low
4,53 HKD
EPS
0,32 HKD
Shares outstanding
3,13 млд
No. of employees
12 миң
Open
4,70 HKD
High
4,74 HKD
Low
4,57 HKD
Mkt. cap
16,29 млд
Avg. vol.
3,85 млн
Volume
3,30 млн
Dividend
3,68%
Quarterly dividend
0,04 HKD
Ex-dividend date
2025-ж., 14-апр.
P/E ratio
14,18
52-wk high
8,97 HKD
52-wk low
4,53 HKD
EPS
0,32 HKD
Shares outstanding
3,13 млд
No. of employees
12 миң
News stories
From web sources and news partners
About Grand Pharmaceutical Group Ltd
CEO-
Employees12,3 миң
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in HKD
Loading Previous Earnings...
Revenue
Net income
All values in HKD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,09 млд
3,09 млд
3,19 млд
3,19 млд
Cost of goods sold
1,50 млд
1,50 млд
1,51 млд
1,51 млд
Cost of revenue
1,50 млд
1,50 млд
1,51 млд
1,51 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,29 млд
1,29 млд
1,13 млд
1,13 млд
Operating expense
1,30 млд
1,30 млд
1,10 млд
1,10 млд
Total operating expenses
2,80 млд
2,80 млд
2,61 млд
2,61 млд
Operating income
285,60 млн
285,60 млн
581,07 млн
581,07 млн
Other non operating income
449,50 миң
449,50 миң
-
-
EBT including unusual items
73,09 млн
73,09 млн
629,04 млн
629,04 млн
EBT excluding unusual items
257,79 млн
257,79 млн
571,85 млн
571,85 млн
Income tax expense
37,88 млн
37,88 млн
94,74 млн
94,74 млн
Effective tax rate
51,82%
51,82%
15,06%
15,06%
Other operating expenses
-8,97 млн
-8,97 млн
-22,46 млн
-22,46 млн
Net income
35,93 млн
35,93 млн
530,77 млн
530,77 млн
Net profit margin
1,16%
1,16%
16,62%
16,62%
Earnings per share
-
-
-
-
Interest and investment income
3,68 млн
3,68 млн
-
-
Interest expense
-40,99 млн
-40,99 млн
-38,38 млн
-38,38 млн
Net interest expenses
-37,31 млн
-37,31 млн
-38,38 млн
-38,38 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
426,70 млн
426,70 млн
747,52 млн
747,52 млн
Gain or loss from assets sale
588,50 миң
588,50 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору